{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:20:16Z","timestamp":1780089616006,"version":"3.54.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.mehy.2006.02.029","type":"journal-article","created":{"date-parts":[[2006,4,5]],"date-time":"2006-04-05T10:48:41Z","timestamp":1144234121000},"page":"626-629","source":"Crossref","is-referenced-by-count":14,"title":["Lithium and antidepressants: Potential agents for the treatment of Rett syndrome"],"prefix":"10.1016","volume":"67","author":[{"given":"Shih-Jen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2006.02.029_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00702-003-0822-z","article-title":"Rett syndrome \u2013 an update","volume":"110","author":"Jellinger","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.mehy.2006.02.029_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.wco.0000162848.99154.9a","article-title":"Rett syndrome","volume":"18","author":"Segawa","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.mehy.2006.02.029_bib3","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.45.8.1581","article-title":"Pervasive neuroanatomic abnormalities of the brain in three cases of Rett\u2019s syndrome","volume":"45","author":"Bauman","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2006.02.029_bib4","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/00001756-199407000-00025","article-title":"Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents","volume":"5","author":"Belichenko","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.mehy.2006.02.029_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s004010050582","article-title":"Morphological study of neocortical areas in Rett syndrome","volume":"93","author":"Belichenko","year":"1997","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.mehy.2006.02.029_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.braindev.2004.09.011","article-title":"Buspirone in Rett syndrome respiratory dysfunction","volume":"27","author":"Andaku","year":"2005","journal-title":"Brain Dev"},{"key":"10.1016\/j.mehy.2006.02.029_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.mehy.2006.02.029_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1212\/WNL.56.5.611","article-title":"MECP 2 gene analysis in classical Rett syndrome and in patients with Rett-like features","volume":"56","author":"Auranen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2006.02.029_bib9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(92)90610-O","article-title":"Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA","volume":"69","author":"Lewis","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2006.02.029_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0092-8674(00)81887-5","article-title":"MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin","volume":"88","author":"Nan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2006.02.029_bib11","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1073\/pnas.0507856102","article-title":"Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2","volume":"102","author":"Young","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2006.02.029_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0896-6273(90)90089-X","article-title":"NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression","volume":"5","author":"Maisonpierre","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2006.02.029_bib13","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/ana.410350705","article-title":"Neurotrophic factors and diseases of the nervous system","volume":"35","author":"Tuszynski","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2006.02.029_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14728222.8.5.391","article-title":"Brain-derived neurotrophic factor as a drug target for CNS disorders","volume":"8","author":"Pezet","year":"2004","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.mehy.2006.02.029_bib15","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1046\/j.1471-4159.1999.0731409.x","article-title":"Extracellular-regulated kinases and phosphatidylinositol3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y","volume":"73","author":"Encinas","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2006.02.029_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.mehy.2006.02.029_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.mehy.2006.02.029_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2006.02.029_bib19","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2006.02.029_bib20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0006-3223(03)00073-8","article-title":"Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain","volume":"54","author":"Altar","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2006.02.029_bib21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuroscience.2004.06.054","article-title":"Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment","volume":"128","author":"De Foubert","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2006.02.029_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2004.07.065","article-title":"The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels","volume":"1024","author":"Jacobsen","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2006.02.029_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s002130100871","article-title":"Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain","volume":"158","author":"Fukumoto","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.mehy.2006.02.029_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","article-title":"Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication","volume":"50","author":"Chen","year":"2001","journal-title":"Biol Psychiat"},{"key":"10.1016\/j.mehy.2006.02.029_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pnpbp.2004.11.009","article-title":"The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study","volume":"29","author":"Aydemir","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.mehy.2006.02.029_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2006.02.029_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1055\/s-2005-871239","article-title":"Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene","volume":"38","author":"Rybakowski","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.mehy.2006.02.029_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1569-9048(03)00034-X","article-title":"Neuronal growth factors and development of respiratory control","volume":"135","author":"Katz","year":"2003","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.mehy.2006.02.029_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1124\/jpet.105.092478","article-title":"Deltamethrin, a pyrethroid insecticide, is a potent inducer for the activity-dependent gene expression of BDNF in neurons","volume":"316","author":"Imamura","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2006.02.029_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/009841096161212","article-title":"Behavioral, neurochemical, and neuromorphological effects of deltamethrin in adult rats","volume":"48","author":"Husain","year":"1996","journal-title":"J Toxicol Environ Health"},{"key":"10.1016\/j.mehy.2006.02.029_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.mehy.2005.10.011","article-title":"Deltamethrin, a pyrethroid insecticide, could be a potential antidepressant agent","volume":"66","author":"Tsai","year":"2006","journal-title":"Med Hypotheses"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987706001460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987706001460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T16:32:12Z","timestamp":1555518732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987706001460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0306987706001460"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2006.02.029","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}